Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christel Renoux

Showing results (91-100 of 126) with videos related to

Pageof 13
Sort By:
JAMA Network Open|March 22, 2024
Concomitant Use of Selective Serotonin Reuptake Inhibitors With Oral Anticoagulants and Risk of Major BleedingAlvi A Rahman, Robert W Platt, Sarah Beradid, et al.
JAMA Psychiatry|January 31, 2019
Association of Aripiprazole With the Risk for Psychiatric Hospitalization, Self-harm, or SuicideFrançois Montastruc, Rui Nie, Simone Loo, et al.
BMJ (Clinical Research Ed.)|March 23, 2018
Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes: population based cohort studyDevin Abrahami, Antonios Douros, Hui Yin, et al.
Current Neuropharmacology|March 3, 2021
Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs) During Pregnancy and the Risk for Autism spectrum disorder (ASD) and Attention deficit hyperactivity disorder (ADHD) in the Offspring: A True Effect or a Bias? A Systematic Review & Meta-AnalysisRegina Leshem, Benjamin Bar-Oz, Orna Diav-Citrin, et al.
Thyroid : Official Journal of the American Thyroid Association|August 6, 2024
Levothyroxine Treatment of Subclinical Hypothyroidism and the Risk of Adverse Cardiovascular EventsOriana Hoi Yun Yu, Christopher Filliter, Kristian B Filion, et al.
Epidemiology (Cambridge, Mass.)|July 21, 2018
Use of Dipeptidyl Peptidase-4 Inhibitors and New-onset Rheumatoid Arthritis in Patients with Type 2 DiabetesAntonios Douros, Devin Abrahami, Hui Yin, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 22, 2019
Parkinsonism associated with gabapentinoid drugs: A pharmacoepidemiologic studyTatiana Pacheco-Paez, François Montastruc, Vanessa Rousseau, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 15, 2020
Reply to: Comment on "Parkinsonism associated with gabapentinoid drugs: A pharmacoepidemiological study"Tatiana Pacheco-Paez, François Montastruc, Vanessa Rousseau, et al.
Journal of Affective Disorders|February 18, 2020
Excess body weight as a predictor of response to treatment with antidepressants in patients with depressive disorderSvetlana Puzhko, Sarah A E Aboushawareb, Irina Kudrina, et al.
International Journal of Cardiology|April 23, 2021
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) inhibitors and the risk for neurocognitive adverse events: A systematic review, meta-analysis and meta-regressionBruria Hirsh Raccah, Alona Yanovsky, Nir Treves, et al.
Pageof 13

Showing results (91-100 of 126) with videos related to

Sort By:
Pageof 13
JAMA Network Open|March 22, 2024
Concomitant Use of Selective Serotonin Reuptake Inhibitors With Oral Anticoagulants and Risk of Major BleedingAlvi A Rahman, Robert W Platt, Sarah Beradid, et al.
JAMA Psychiatry|January 31, 2019
Association of Aripiprazole With the Risk for Psychiatric Hospitalization, Self-harm, or SuicideFrançois Montastruc, Rui Nie, Simone Loo, et al.
BMJ (Clinical Research Ed.)|March 23, 2018
Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes: population based cohort studyDevin Abrahami, Antonios Douros, Hui Yin, et al.
Current Neuropharmacology|March 3, 2021
Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs) During Pregnancy and the Risk for Autism spectrum disorder (ASD) and Attention deficit hyperactivity disorder (ADHD) in the Offspring: A True Effect or a Bias? A Systematic Review & Meta-AnalysisRegina Leshem, Benjamin Bar-Oz, Orna Diav-Citrin, et al.
Thyroid : Official Journal of the American Thyroid Association|August 6, 2024
Levothyroxine Treatment of Subclinical Hypothyroidism and the Risk of Adverse Cardiovascular EventsOriana Hoi Yun Yu, Christopher Filliter, Kristian B Filion, et al.
Epidemiology (Cambridge, Mass.)|July 21, 2018
Use of Dipeptidyl Peptidase-4 Inhibitors and New-onset Rheumatoid Arthritis in Patients with Type 2 DiabetesAntonios Douros, Devin Abrahami, Hui Yin, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 22, 2019
Parkinsonism associated with gabapentinoid drugs: A pharmacoepidemiologic studyTatiana Pacheco-Paez, François Montastruc, Vanessa Rousseau, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 15, 2020
Reply to: Comment on "Parkinsonism associated with gabapentinoid drugs: A pharmacoepidemiological study"Tatiana Pacheco-Paez, François Montastruc, Vanessa Rousseau, et al.
Journal of Affective Disorders|February 18, 2020
Excess body weight as a predictor of response to treatment with antidepressants in patients with depressive disorderSvetlana Puzhko, Sarah A E Aboushawareb, Irina Kudrina, et al.
International Journal of Cardiology|April 23, 2021
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) inhibitors and the risk for neurocognitive adverse events: A systematic review, meta-analysis and meta-regressionBruria Hirsh Raccah, Alona Yanovsky, Nir Treves, et al.
Pageof 13